Question 1

Does U.S. Bancorp own SNDX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, U.S. Bancorp holds 4,544 shares of SNDX (Syndax Pharmaceuticals), worth $99,332.

Question 2

How many shares of SNDX does U.S. Bancorp own?

Accepted Answer

As of its Q2 2026 13F, U.S. Bancorp holds 4,544 shares of SNDX (Syndax Pharmaceuticals).

Question 3

What is U.S. Bancorp's SNDX position worth?

Accepted Answer

As of its Q2 2026 13F, U.S. Bancorp's SNDX position is worth $99,332.

Question 4

Is U.S. Bancorp buying or selling SNDX?

Accepted Answer

In Q2 2026, U.S. Bancorp reduced its SNDX position by 29 shares (-0.6%).

Question 5

When did U.S. Bancorp first buy SNDX?

Accepted Answer

U.S. Bancorp already held SNDX in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	4,544	-0.6%	$99,332	0.0%	$21.86	0
2026-Q1	Increased	4,573	+1.1%	$106,825	0.0%	$21.40	22
2025-Q4	Unchanged	4,521	0.0%	$94,986	0.0%	$20.74	0
2025-Q3	Increased	4,521	+3.3%	$69,556	0.0%	$15.56	22
2025-Q2	Decreased	4,378	-13.4%	$41,000	0.0%	$9.04	0
2025-Q1	Decreased	5,055	-5.6%	$62,101	0.0%	$13.18	0
2024-Q4	Decreased	5,355	-33.4%	$70,793	0.0%	$12.52	0
2024-Q3	Increased	8,043	+1.6%	$154,828	0.0%	$18.89	23